title: Diabetes drug update: how 4 new options stack up.
authors.affiliation: University of Florida College of Pharmacy, PO Box 100486, Gainseville, FL 32610-0486, USA. jtaylor@cop.ufl.edu
authors.forename: James R
authors.initials: JR
authors.lastname: Taylor
authors.forename: Kendall M
authors.initials: KM
authors.lastname: Campbell
mesh_terms: D000280:Administration, Inhalation; D000682:Amyloid / Q000008:administration & dosage; D001786:Blood Glucose / Q000187:drug effects; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016503:Drug Delivery Systems; D000077270:Exenatide; D005194:Family Practice; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage; D058228:Islet Amyloid Polypeptide; D008297:Male; D010455:Peptides / Q000008:administration & dosage; D011379:Prognosis; D011719:Pyrazines / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D000068900:Sitagliptin Phosphate; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage; D014688:Venoms / Q000008:administration & dosage
chemical_list: D000682:Amyloid; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D010455:Peptides; D011719:Pyrazines; D014230:Triazoles; D014688:Venoms; D000077270:Exenatide; C105254:pramlintide; D000068900:Sitagliptin Phosphate